Dmitry B. Rubinov , Veronica G. Zinovich , Alexander M. Scherbakov , Tatyana V. Chukarina , Danila V. Sorokin , Sviatlana E. Ohurtsova , Elena V. Shafranovskaya , Valeryia V. Laptsevich , Alexandra L. Mikhaylova , Fedor B. Bogdanov , Alexander V. Baranovsky , Raman M. Puzanau , Yury G. Pakhadnia , Fedor A. Lakhvich , Yuri A. Piven
{"title":"异黄酮非芳香环A类似物7,8-二氢- 4h -铬-4,5(6H)-二酮的简易制备及其抗增殖作用的评价","authors":"Dmitry B. Rubinov , Veronica G. Zinovich , Alexander M. Scherbakov , Tatyana V. Chukarina , Danila V. Sorokin , Sviatlana E. Ohurtsova , Elena V. Shafranovskaya , Valeryia V. Laptsevich , Alexandra L. Mikhaylova , Fedor B. Bogdanov , Alexander V. Baranovsky , Raman M. Puzanau , Yury G. Pakhadnia , Fedor A. Lakhvich , Yuri A. Piven","doi":"10.1016/j.bioorg.2025.108960","DOIUrl":null,"url":null,"abstract":"<div><div>In this article, we describe a facile method for the synthesis of a novel class of compounds – 3-aryl-7,8-dihydro-4<em>H</em>-chromene-4,5(6<em>H</em>)-diones. The target compounds were prepared from easily accessible 2-(2-arylacetyl)cyclohexane-1,3-diones using a low-cost dimethylformamide-dimethyl sulfate adduct in the presence of triethylamine. The obtained compounds, which can be considered non-aromatic cycle A analogs of isoflavones, demonstrated moderate antiproliferative activity in the micromolar IC<sub>50</sub> range and modest selectivity toward HER2-positive cancer cells. A molecular modeling study suggested that their possible mechanism of action may involve HER2 inhibition. Additionally, by introducing a 3-chloro-4-((3-fluorobenzyl)oxy)phenyl group into the structure of the reported compounds, we designed and synthesized compound <strong>4o</strong> as a potential selective HER2 inhibitor. Two compounds, <strong>4b</strong> and <strong>4o</strong>, which had different predicted binding modes to HER2, were tested <em>in vitro</em> for kinase activity inhibition against eight tyrosine kinases. At a concentration of 1 μM, compound <strong>4b</strong> inhibited HER2 and HER4 by 74 % and 69 %, respectively. At the same concentration, compound <strong>4o</strong> significantly inhibited only HER2 by 84 %. However, immunoblotting in A431 cells treated with <strong>4b</strong> or <strong>4o</strong> unexpectedly showed a reduction in total HER2 expression rather than in phosphorylated HER2 (p-HER2). Furthermore, both compounds reduced cyclin D1 level and stimulated PARP cleavage.</div></div>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"165 ","pages":"Article 108960"},"PeriodicalIF":4.7000,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A facile method for the preparation of 7,8-dihydro-4H-chromene-4,5(6H)-diones as non-aromatic cycle A analogs of isoflavones and their evaluation as antiproliferative agents\",\"authors\":\"Dmitry B. Rubinov , Veronica G. Zinovich , Alexander M. Scherbakov , Tatyana V. Chukarina , Danila V. Sorokin , Sviatlana E. Ohurtsova , Elena V. Shafranovskaya , Valeryia V. Laptsevich , Alexandra L. Mikhaylova , Fedor B. Bogdanov , Alexander V. Baranovsky , Raman M. Puzanau , Yury G. Pakhadnia , Fedor A. Lakhvich , Yuri A. Piven\",\"doi\":\"10.1016/j.bioorg.2025.108960\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>In this article, we describe a facile method for the synthesis of a novel class of compounds – 3-aryl-7,8-dihydro-4<em>H</em>-chromene-4,5(6<em>H</em>)-diones. The target compounds were prepared from easily accessible 2-(2-arylacetyl)cyclohexane-1,3-diones using a low-cost dimethylformamide-dimethyl sulfate adduct in the presence of triethylamine. The obtained compounds, which can be considered non-aromatic cycle A analogs of isoflavones, demonstrated moderate antiproliferative activity in the micromolar IC<sub>50</sub> range and modest selectivity toward HER2-positive cancer cells. A molecular modeling study suggested that their possible mechanism of action may involve HER2 inhibition. Additionally, by introducing a 3-chloro-4-((3-fluorobenzyl)oxy)phenyl group into the structure of the reported compounds, we designed and synthesized compound <strong>4o</strong> as a potential selective HER2 inhibitor. Two compounds, <strong>4b</strong> and <strong>4o</strong>, which had different predicted binding modes to HER2, were tested <em>in vitro</em> for kinase activity inhibition against eight tyrosine kinases. At a concentration of 1 μM, compound <strong>4b</strong> inhibited HER2 and HER4 by 74 % and 69 %, respectively. At the same concentration, compound <strong>4o</strong> significantly inhibited only HER2 by 84 %. However, immunoblotting in A431 cells treated with <strong>4b</strong> or <strong>4o</strong> unexpectedly showed a reduction in total HER2 expression rather than in phosphorylated HER2 (p-HER2). Furthermore, both compounds reduced cyclin D1 level and stimulated PARP cleavage.</div></div>\",\"PeriodicalId\":257,\"journal\":{\"name\":\"Bioorganic Chemistry\",\"volume\":\"165 \",\"pages\":\"Article 108960\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-09-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioorganic Chemistry\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0045206825008405\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic Chemistry","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0045206825008405","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
A facile method for the preparation of 7,8-dihydro-4H-chromene-4,5(6H)-diones as non-aromatic cycle A analogs of isoflavones and their evaluation as antiproliferative agents
In this article, we describe a facile method for the synthesis of a novel class of compounds – 3-aryl-7,8-dihydro-4H-chromene-4,5(6H)-diones. The target compounds were prepared from easily accessible 2-(2-arylacetyl)cyclohexane-1,3-diones using a low-cost dimethylformamide-dimethyl sulfate adduct in the presence of triethylamine. The obtained compounds, which can be considered non-aromatic cycle A analogs of isoflavones, demonstrated moderate antiproliferative activity in the micromolar IC50 range and modest selectivity toward HER2-positive cancer cells. A molecular modeling study suggested that their possible mechanism of action may involve HER2 inhibition. Additionally, by introducing a 3-chloro-4-((3-fluorobenzyl)oxy)phenyl group into the structure of the reported compounds, we designed and synthesized compound 4o as a potential selective HER2 inhibitor. Two compounds, 4b and 4o, which had different predicted binding modes to HER2, were tested in vitro for kinase activity inhibition against eight tyrosine kinases. At a concentration of 1 μM, compound 4b inhibited HER2 and HER4 by 74 % and 69 %, respectively. At the same concentration, compound 4o significantly inhibited only HER2 by 84 %. However, immunoblotting in A431 cells treated with 4b or 4o unexpectedly showed a reduction in total HER2 expression rather than in phosphorylated HER2 (p-HER2). Furthermore, both compounds reduced cyclin D1 level and stimulated PARP cleavage.
期刊介绍:
Bioorganic Chemistry publishes research that addresses biological questions at the molecular level, using organic chemistry and principles of physical organic chemistry. The scope of the journal covers a range of topics at the organic chemistry-biology interface, including: enzyme catalysis, biotransformation and enzyme inhibition; nucleic acids chemistry; medicinal chemistry; natural product chemistry, natural product synthesis and natural product biosynthesis; antimicrobial agents; lipid and peptide chemistry; biophysical chemistry; biological probes; bio-orthogonal chemistry and biomimetic chemistry.
For manuscripts dealing with synthetic bioactive compounds, the Journal requires that the molecular target of the compounds described must be known, and must be demonstrated experimentally in the manuscript. For studies involving natural products, if the molecular target is unknown, some data beyond simple cell-based toxicity studies to provide insight into the mechanism of action is required. Studies supported by molecular docking are welcome, but must be supported by experimental data. The Journal does not consider manuscripts that are purely theoretical or computational in nature.
The Journal publishes regular articles, short communications and reviews. Reviews are normally invited by Editors or Editorial Board members. Authors of unsolicited reviews should first contact an Editor or Editorial Board member to determine whether the proposed article is within the scope of the Journal.